Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sun Pharma To Stop Selling Oxaliplatin Injection
Eloxatin is a registered trademark of sanofi aventis US. It is an antineoplastic that works by killing cancer cells and slowing tumor growth, is a cancer medication that
Eloxatin is a registered trademark of sanofi aventis US. It is an antineoplastic that works by killing cancer cells and slowing tumor growth, is a cancer medication that
Spherix said that reduction of triglyceride levels is a secondary endpoint of the Phase 3 trial. Results from the trial are expected later this summer. Spherix’s unblinded Phase
According to OraSure Technologies, OraQuick is a test strip and does not require an instrument for diagnosis. It takes about 20 minutes to obtain results from the test
P&G said that the recalling is part of the precautionary step the company is taking after finding that the child-resistant cap does not work in a small percentage
Taspoglutide, the first once weekly glucagon-like peptide-1 (GLP-1) analogue based on a human sequence, originating from Ipsen’s research is developed by Roche. The compound is similar to the
Amylin and Lilly have presented the findings of the trial at the 70th Annual Scientific Sessions of the American Diabetes Association (ADA) in Orlando, Fla. The retrospective study
According to the study the addition of Dapagliflozin achieved reductions in the primary endpoint, glycosylated hemoglobin level (HbA1c), in inadequately controlled type 2 diabetes patients who were treated
Kowa and Abbott said that with the current agreement Pitavastatin will now be marketed in five continents. Reportedly, Abbott is now expected to apply for regulatory approvals to
Dr Morich, after holding important roles in Bayer, is currently CEO of Noxxon Pharma, and also is one of the Takeda global advisory board members. As EVP of
Vpriv is Shire’s enzyme replacement therapy (ERT) for the treatment of type 1 Gaucher disease. Shire said that the CHMP positive opinion is expected to be forwarded to